A Pilot Study to Assess the Efficacy and Safety of Topical SR-T100 Gel in the Treatment of Human Vulva Pre-cancerous Lesions (Vulvar Intraepithelial Neoplasia; VIN) and Cutaneous Condyloma(External Genital Warts; EGWs).
Phase of Trial: Phase 0
Latest Information Update: 12 Jun 2014
At a glance
- Drugs SR T100 (Primary)
- Indications Genital warts; Vulvar intraepithelial neoplasia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 21 Apr 2014 Trial status changed to completed as reported by ClinicalTrials.gov.
- 04 Sep 2012 New trial record